SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-018340
Filing Date
2004-02-10
Accepted
2004-02-10 16:07:43
Documents
14
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1412704
3 CERTIFICATE OF AMENDMENT dex31e.htm EX-3.1E 6911
4 1994 EMPLOYEE STOCK PURCHASE PLAN dex104d.htm EX-10.4D 43852
5 1998 STOCK OPTION PLAN dex105c.htm EX-10.5C 77402
6 FORM OF AGREEMENT PROVIDING SPECIFIED BENEFITS dex107b.htm EX-10.7B 31618
7 LEASE AGREEMENT BETWEEN REGISTRANT AND UNIVERSITY OF UTAH dex1015.htm EX-10.15 147148
8 AGREEMENT TO SUBLEASE BETWEEN HARRISON & STAR, INC dex1016.htm EX-10.16 66229
9 TERM SHEET BETWEEN MARS DISCOVERY DISTRICT AND THE REGISTRANT dex1017.htm EX-10.17 80140
10 COMPUTATION RATIO OF EARNINGS AVAILABLE TO COVER FIXED CHARGES dex121.htm EX-12.1 28096
11 LIST OF SUBSIDIARIES dex211.htm EX-21.1 3638
12 CONSENT OF INDEPENDENT AUDITORS dex231.htm EX-23.1 2414
13 302 CERTIFICATION OF THE CEO dex311.htm EX-31.1 9038
14 302 CERTIFICATION OF THE CFO dex312.htm EX-31.2 9046
15 906 CERTIFICATION OF THE CEO & CFO dex32.htm EX-32 6418
  Complete submission text file 0001193125-04-018340.txt   1927845
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23272 | Film No.: 04582125
SIC: 2836 Biological Products, (No Diagnostic Substances)